Abstract:Newborn screening (NBS) plays a significant role in reducing the risk of birth defects. NBS in China began in the early 1980s. Under the protection of laws and regulations and the leadership of the national health administration, approved screening centers in public hospitals took the responsibility for publicity, screening, diagnosis, treatment, follow-up and management of birth defects. As of 2022, 31 provinces (autonomous regions and municipalities directly under the central government) have carried out NBS for phenylketonuria, congenital hypothyroidism, and hearing loss, 23 provinces have carried out screening for glucose-6-phosphate dehydrogenase (with a screening rate of 89.24%), and 24 provinces have carried out screening for congenital adrenal cortical hyperplasia (91.45% screening rate). Over the past four decades, screening techniques have evolved from bacterial inhibition, fluorescence analysis, and tandem mass spectrometry for the detection of biochemical markers to genetic testing, which has greatly contributed to the expansion of the types of diseases screened for. The combined use of metabolomics and genomics is currently being explored. Effective management and rigorous quality control of NBS are prerequisites for improving the quality and ensuring the accuracy of screening. The Quality Management System for Newborn Screening System Network (QMS-NBS), established by the National Center for Clinical Laboratories, covers all screening centers and related blood collection agencies. The operation of the QMS-NBS allows the quality and performance of screening to be transparent and measurable, ensuring the quality and efficiency of screening. This article provides an overview of the history of NBS, especially the evolution of policies for the NBS in China, the construction of screening institutions, the number of newborns screened, the incidence rates of screened diseases, the changes in screening technology, the expansion of new diseases screened for, and the quality control of NBS. Overall, the progress in NBS in China has not only benefited from the development and standardization at the technological level, but also benefited from the construction of policies, regulations and ethics.

Up-to-date quality survey and evaluation of neonatal screening programs in China

Study of the Administrative Approach of Newborns Screening in Zhejiang Province

[Retrospective Study on Neonatal Screening for Congenital Hypothyroidism and Phenylketonuria in China in the Past 22 Years].

The Chinese Neonatal Network: a New Platform of National Collaboration on Quality Improvement for Preterm Infants

Neonatal screening for congenital hypothyroidism and phenylketonuria in China

Epidemiological Survey on Newborns Born at the Obstetric Departments in Hospitals in Mid-Southern Region of China in 2005.

Analysis of the characteristics and management of critical values in a newborn tertiary center in China

Newborn Screening in Zhejiang, China

Survey of Birth Defects and Discussion on Intervention Mode in Nanshan District of Shenzhen City

A Multicenter Prospective Study of Next-Generation Sequencing-Based Newborn Screening for Monogenic Genetic Diseases in China

Acute Care of At-Risk Newborns (acorn): Quantitative and Qualitative Educational Evaluation of the Program in a Region of China

Progress of newborn screening in China

The Profile of Newborn Screening Coverage in China.

Overview of the Viability Assessment of Neonatal Disease Screening in China

Status of the neonatal follow-up system in China: survey and analysis

The Status of Quality Control Investigation and Analysis for Maternal Serum Marker of Prenatal Screening Laboratories in China

Data Quality Improvement and Internal Data Audit of the Chinese Neonatal Network Data Collection System

[Operation of Prenatal Ultrasound Screening Institutions in Beijing from 2010 to 2015].

A National Quality Improvement Program on Ultrasound Department in China: A Controlled Cohort Study of 1297 Public Hospitals

Investigation of Ultrasound Screening Efficiency for Neural Tube Defects During Pregnancy in Rural Areas of China